D-1381-2020 Class III Terminated

Recalled by Biogen MA Inc. — Research Triangle Park, NC

FDA drug recall D-1381-2020 was initiated by Biogen MA Inc. on Jun 23, 2020 and is designated Class III. Reason for recall: cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control. The recall status is terminated (terminated Feb 11, 2021). Affected quantity: 3,922 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 15, 2020
Initiation Date
Jun 23, 2020
Termination Date
Feb 11, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,922 bottles

Product description

Tecfidera (dimethyl fumarate) delayed-release capsules, 240 mg, 60-count bottle, Rx only, Manufactured by: Biogen Inc., Cambridge, MA 02142, NDC 64406-006-02

Reason for recall

cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.

Distribution pattern

Product was distributed to wholesalers/distributors in KY, OH & MS.

Code information

Lot # SH0274, Exp 2/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1381-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1381-2020. Report a data issue: hello@regdatalab.com.